Head of Investor Relations
Amneal Pharmaceuticals, Inc. (AMRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMRX alertsTony DiMaio is recorded as Head of Investor Relations at Amneal Pharmaceuticals, Inc. (AMRX). Tony DiMaio has spoken on 3 earnings calls across 1 company, most recently for Amneal Pharmaceuticals, Inc. on February 27, 2026. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.
“Good morning, and thank you for joining Amnil Pharmaceuticals Fourth Quarter 2025 Earnings Call. Today, we issued a press release reporting Q4 results.”
“Good morning, and thank you for joining Amnil Pharmaceuticals' third quarter 2025 earnings call. Today, we issued a press release reporting Q3 results.”
“Good morning and thank you for joining Amnil Pharmaceuticals First Quarter 2025 Earnings Call. Today we issued a press release reporting Q1 results.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
